Alignment on potency assays is the critical one for me. That had the potential to blow out approval for a long time given it is a differently differentiated MSC to Rynoncil.
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Maintains Momentum with FDA
MSB
mesoblast limited
Add to My Watchlist
2.02%
!
$1.82

Ann: Mesoblast Maintains Momentum with FDA, page-14
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.82 |
Change
-0.038(2.02%) |
Mkt cap ! $2.328B |
Open | High | Low | Value | Volume |
$1.88 | $1.94 | $1.82 | $7.373M | 3.931M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 61822 | $1.82 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.83 | 44187 | 36 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 18409 | 1.825 |
29 | 107000 | 1.820 |
22 | 57113 | 1.815 |
10 | 72529 | 1.810 |
7 | 22482 | 1.805 |
Price($) | Vol. | No. |
---|---|---|
1.830 | 40193 | 25 |
1.835 | 17457 | 13 |
1.840 | 53208 | 13 |
1.845 | 109889 | 11 |
1.850 | 15689 | 8 |
Last trade - 14.00pm 17/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online